How European Research Projects Can Support Vaccination Strategies : The Case of the ORCHESTRA Project for SARS-CoV-2
ORCHESTRA ("Connecting European Cohorts to Increase Common and Effective Response To SARS-CoV-2 Pandemic") is an EU-funded project which aims to help rapidly advance the knowledge related to the prevention of the SARS-CoV-2 infection and the management of COVID-19 and its long-term sequelae. Here, we describe the early results of this project, focusing on the strengths of multiple, international, historical and prospective cohort studies and highlighting those results which are of potential relevance for vaccination strategies, such as the necessity of a vaccine booster dose after a primary vaccination course in hematologic cancer patients and in solid organ transplant recipients to elicit a higher antibody titer, and the protective effect of vaccination on severe COVID-19 clinical manifestation and on the emergence of post-COVID-19 conditions. Valuable data regarding epidemiological variations, risk factors of SARS-CoV-2 infection and its sequelae, and vaccination efficacy in different subpopulations can support further defining public health vaccination policies.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
---|---|
Enthalten in: |
Vaccines - 11(2023), 8 vom: 14. Aug. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Azzini, Anna Maria [VerfasserIn] |
---|
Links: |
---|
Themen: |
COVID-19 |
---|
Anmerkungen: |
Date Revised 29.08.2023 published: Electronic Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.3390/vaccines11081361 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM361301111 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM361301111 | ||
003 | DE-627 | ||
005 | 20231226084841.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/vaccines11081361 |2 doi | |
028 | 5 | 2 | |a pubmed24n1204.xml |
035 | |a (DE-627)NLM361301111 | ||
035 | |a (NLM)37631929 | ||
035 | |a (PII)1361 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Azzini, Anna Maria |e verfasserin |4 aut | |
245 | 1 | 0 | |a How European Research Projects Can Support Vaccination Strategies |b The Case of the ORCHESTRA Project for SARS-CoV-2 |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 29.08.2023 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a ORCHESTRA ("Connecting European Cohorts to Increase Common and Effective Response To SARS-CoV-2 Pandemic") is an EU-funded project which aims to help rapidly advance the knowledge related to the prevention of the SARS-CoV-2 infection and the management of COVID-19 and its long-term sequelae. Here, we describe the early results of this project, focusing on the strengths of multiple, international, historical and prospective cohort studies and highlighting those results which are of potential relevance for vaccination strategies, such as the necessity of a vaccine booster dose after a primary vaccination course in hematologic cancer patients and in solid organ transplant recipients to elicit a higher antibody titer, and the protective effect of vaccination on severe COVID-19 clinical manifestation and on the emergence of post-COVID-19 conditions. Valuable data regarding epidemiological variations, risk factors of SARS-CoV-2 infection and its sequelae, and vaccination efficacy in different subpopulations can support further defining public health vaccination policies | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a cohort study | |
650 | 4 | |a data harmonization | |
650 | 4 | |a fragile population | |
650 | 4 | |a healthcare workers | |
650 | 4 | |a public health | |
650 | 4 | |a vaccination | |
700 | 1 | |a Canziani, Lorenzo Maria |e verfasserin |4 aut | |
700 | 1 | |a Davis, Ruth Joanna |e verfasserin |4 aut | |
700 | 1 | |a Mirandola, Massimo |e verfasserin |4 aut | |
700 | 1 | |a Hoelscher, Michael |e verfasserin |4 aut | |
700 | 1 | |a Meyer, Laurence |e verfasserin |4 aut | |
700 | 1 | |a Laouénan, Cédric |e verfasserin |4 aut | |
700 | 1 | |a Giannella, Maddalena |e verfasserin |4 aut | |
700 | 1 | |a Rodríguez-Baño, Jesús |e verfasserin |4 aut | |
700 | 1 | |a Boffetta, Paolo |e verfasserin |4 aut | |
700 | 1 | |a Mates, Dana |e verfasserin |4 aut | |
700 | 1 | |a Malhotra-Kumar, Surbhi |e verfasserin |4 aut | |
700 | 1 | |a Scipione, Gabriella |e verfasserin |4 aut | |
700 | 1 | |a Stellmach, Caroline |e verfasserin |4 aut | |
700 | 1 | |a Rinaldi, Eugenia |e verfasserin |4 aut | |
700 | 1 | |a Hasenauer, Jan |e verfasserin |4 aut | |
700 | 1 | |a Tacconelli, Evelina |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Vaccines |d 2012 |g 11(2023), 8 vom: 14. Aug. |w (DE-627)NLM239212347 |x 2076-393X |7 nnns |
773 | 1 | 8 | |g volume:11 |g year:2023 |g number:8 |g day:14 |g month:08 |
856 | 4 | 0 | |u http://dx.doi.org/10.3390/vaccines11081361 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 11 |j 2023 |e 8 |b 14 |c 08 |